missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ 14-3-3 theta Polyclonal Antibody

Description
This antibody is predicted to react with canine, mouse and rat based on sequence homology. This antibody is tested in Peptide ELISA: antibody detection limit dilution 4,000.
This gene product belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 99% identical to the mouse and rat orthologs. This gene is upregulated in patients with amyotrophic lateral sclerosis. It contains in its 5' UTR a 6 bp tandem repeat sequence which is polymorphic, however, there is no correlation between the repeat number and the disease.
Specifications
Specifications
| Antigen | 14-3-3 theta |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 |
| Gene | YWHAQ |
| Gene Accession No. | P27348 |
| Gene Alias | 14-3-3; 14-3-3 protein tau; 14-3-3 protein T-cell; 14-3-3 protein theta; 14-3-3 tau; 14-3-3 theta; 14-3-3t; 1C5; 2700028P07Rik; AA409740; AU021156; HS1; OTTHUMP00000165887; Protein HS1; protein tau; protein, theta; R74690; tyrosine 3/tryptophan 5 -monooxygenase activation protein, theta polypeptide; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide; Unknown (protein for MGC:127486); YWHAQ |
| Gene Symbols | YWHAQ |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?